Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. ANDREJAK, O. PEUCHANT, N. VEZIRIS, C. SEGONDS, D. TERRU, F. HAMDAD, A. LAGRANGE, V. LALANDE, C. LAURAIN, P. BEMER (Amiens, Bordeaux, Paris, Toulouse, Montpellier, Nancy, Nantes, France). LATE-BREAKING ABSTRACT: Outcome and prognostic factors of nontuberculous mycobacteriosis in France: a cohort study of 192 patients. Eur Respir J 2013; 42: Suppl. 57, 4412

Member's Comments

No comment yet.

Related content which might interest you: Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Clinical resuts of therapy for non-tuberculous myocardium avium complex -Multicentric retrospective study of 581 patients in Japan Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Epidemiological and clinical features of non tuberculous mycobacteria infection (NTM) in a five-year single centre experience Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Non-tuberculous mycobacterial lung diseases: Retrospective analysis of 42 cases Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Risk factors of pneumocytis pneumoniae in solid tumours: A case-control study Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study Source: Eur Respir J, 55 (1) 1900798; 10.1183/13993003.00798-2019 Year: 2020 Relation between the empiric initial therapy of S.pneumoniae community-acquired pneumonia (SP-CAP) and mortality in thirty days of outcome. On behalf of Pneumococcal Pneumonia Cooperative Study Group, Grupo TIR, SEPAR Source: Annual Congress 2003 - New aspects of community acquired pneumonia Year: 2003 Predictors of mortality in otherwise healthy patients with pulmonary tuberculosis: A retrospective cohort study Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Risk factors for tuberculosis relapse in Polish patients Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Risk factors for active tuberculosis in patients with inflammatory bowel disease: A case-control study Source: International Congress 2015 – Latent TB infection and screening Year: 2015 Prevalence of nontuberculosis mycobacterial in patients with bronchiectasis: A meta-analysis Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 LATE-BREAKING ABSTRACT: Pneumonia incidence and risk factors in patients with acute leukemia Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Analysis of nontuberculous mycobacteriosis deaths in official statistics, 1970-2010, and a recent clinical cohort study for the estimation of prevalence rate in Japan Source: Annual Congress 2013 –Interesting research questions Year: 2013 Clinical importance of pulmonary nontuberculous mycobacteria isolated among HIV-positive individuals in Ghana Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 Plaque-related vs. plaque-unrelated cardio and cerebrovascular events (CCVE) in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study (ClinicalTrials: NCT01143155) Source: International Congress 2014 – Immunology of respiratory infections Year: 2014 Characteristics of patients with pulmonary non-tuberculous Mycobacterial infection in bronchiectasis: Data from the EMBARC registry Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018 Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Clinical characteristics of 11 cases of pulmonary abscess in children Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013